EMA to review Sanofi/Regeneron’s skin disease treatment Dupixent
Sanofi and Regeneron Pharmaceuticals have announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application…
Pharmaceuticals, Biotechnology and Life Sciences
Sanofi and Regeneron Pharmaceuticals have announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application…
European Commission (EC) has granted an additional indication for Novartis’s Lucentis (ranibizumab) to treat patients with eye disease due to…
Acute leukemia focused pharmaceutical company Erytech Pharma, has announced the closing of a private placement of 793,877 ordinary shares to…
Novartis on Wednesday announced positive results from the first large-scale study exploring the effects of directly switching symptomatic, non-frequently exacerbating…
Bristol-Myers Squibb Company has declared an increase of 2.6% percent in the its quarterly dividend, beginning in the first quarter…
European Patent Office has granted ValiRx’s patent covering its major therapeutic compound VAL201, including prostate cancer, the pharmaceutical company said on…
InnovaDerma, a UK -based company focused on hair loss, hair care, self-tanning and skin rejuvenation, has raised £539,999.60 through the…
Bayer and Boehringer Ingelheim Vetmedica, Inc. (BIVI) have made a deal for Bayer to buy BIVI’s Cydectin bovine and ovine…
Biocartis Group NV has launched its second liquid biopsy assay, the Idylla ctKRAS Mutation Assay, which was developed in partnership…
The U.S. Food and Drug Administration (FDA) has granted “Fast Track” status to French biopharmaceutical company Neovacs’s IFNalpha Kinoid in…